| Identification | Back Directory | [Name]
Loxoprofen Ring-opening IMpurity | [CAS]
1091621-61-2 | [Synonyms]
Loxoprofen Impurity K
Loxoprofen Impurity 12
Loxoprofen Ring-opening IMpurity
Loxoprofen sodium degrades impurity B
4-(1-Carboxyethyl)-δ-oxo-benzenehexanoic Acid
Benzenehexanoic acid, 4-(1-carboxyethyl)-δ-oxo-
Bendamustine Impurity: 6-[4-(1-Carboxy-ethyl)-phenyl]-5-oxo-hexanoic acid | [Molecular Formula]
C15H18O5 | [MDL Number]
MFCD30718687 | [MOL File]
1091621-61-2.mol | [Molecular Weight]
278.3 |
| Chemical Properties | Back Directory | [Boiling point ]
504.8±35.0 °C(Predicted) | [density ]
1.238±0.06 g/cm3(Predicted) | [pka]
4.32±0.10(Predicted) | [InChI]
InChI=1S/C15H18O5/c1-10(15(19)20)12-7-5-11(6-8-12)9-13(16)3-2-4-14(17)18/h5-8,10H,2-4,9H2,1H3,(H,17,18)(H,19,20) | [InChIKey]
ALZUIVGLLMTAMW-UHFFFAOYSA-N | [SMILES]
C(C1C=CC(=CC=1)CC(=O)CCCC(=O)O)(C)C(=O)O |
| Hazard Information | Back Directory | [Uses]
4-(1-Carboxyethyl)-δ-oxo-benzenehexanoic Acid is a degradation product of Loxoprofen (L472900, Na salt), a non-selective nonsteroidal anti-inflammatory drug (NSAID) that has been effective in reducing atherosclerosis in mice by reducing inflammation. It becomes active after metabolism in the body and inhibits the activation of cyclooxygenase. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
|